Therapeutic potential of epidermal growth factor receptor-related protein [1]

Molecular Cancer Therapeutics

Volumn 5, Issue 11, 2006, Pages 2954-

  Reiter, Jill L ^a   Maihle, Nita J ^a   Clinton, Gail M ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CETUXIMAB; COMPLEMENTARY DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR RELATED PROTEIN; ERLOTINIB; GEFITINIB; LIGAND; MONOCLONAL ANTIBODY; PROLINE DIPEPTIDASE; PROTEIN TYROSINE KINASE INHIBITOR; TRASTUZUMAB;

CANCER GROWTH; CANCER INHIBITION; CANCER PATIENT; CARCINOGENESIS; CHROMOSOME 1; CHROMOSOME 14; DNA STRUCTURE; GENE SEQUENCE; HUMAN; IMMUNE RESPONSE; LETTER; LIGAND BINDING; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN FAMILY; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; FEMALE; GLYCOPROTEINS; HUMANS; MALE; NEOPLASMS; RATS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 33845226182     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-05-0404     Document Type: Letter

References (9)

1. Marciniak DJ, Rishi AK, Sarkar FH, Majumdar AP. Epidermal growth factor receptor-related peptide inhibits growth of PC-3 prostate cancer cells. Mol Cancer Ther 2004;3:1615-21.
2. Xu H, Yu Y, Marciniak D, et al. Epidermal growth factor receptor (EGFR)-related protein inhibits multiple members of the EGFR family in colon and breast cancer cells. Mol Cancer Ther 2005;4:435-42.
3. Basu A, Raghunath M, Bishayee S, Das M. Inhibition of tyrosine kinase activity of the epidermal growth factor (EGF) receptor by a truncated receptor form that binds to EGF: role for interreceptor interaction in kinase regulation. Mol Cell Biol 1989;9:671-7.
4. Lee H, Akita RW, Sliwkowski MX, Maihle NJ. A naturally occurring secreted human ErbB3 receptor isoform inhibits heregulin-stimulated activation of ErbB2, ErbB3, and ErbB4. Cancer Res 2001;61:4467-73.
5. Doherty JK, Bond C, Jardim A, Adelman JP, Clinton GM. The HER-2/neu receptor tyrosine kinase gene encodes a secreted autoinhibitor. Proc Natl Acad Sci U S A 1999;96:10869-74.
6. Lee H, Maihle NJ. Isolation and characterization of four alternate c-erbB3 transcripts expressed in ovarian carcinoma-derived cell lines and normal human tissues. Oncogene 1998;16:3243-52.
7. Reiter JL, Threadgill DW, Eley GD, et al. Comparative genomic sequence analysis and isolation of human and mouse alternative EGFR transcripts encoding truncated receptor isoforms. Genomics 2001;71:1-20.
8. Yu Y, Rishi AK, Turner JR, et al. Cloning of a novel EGFR-related peptide: a putative negative regulator of EGFR. Am J Physiol Cell Physiol 2001;280:C1083-9.
9. Moon WS, Tarnawski AS, Chai J, Yang JT, Majumdar AP. Reduced expression of epidermal growth factor receptor related protein in gastric cancer. Gut 2005;54:201-6.